Digital Therapeutics in the Treatment of Substance Use Disorders: State of the Science & Vision for the Future
Digital therapeutics–software used to prevent, treat, or manage a medical disorder or disease–are redefining the future of healthcare. Digital therapeutics package an entire model of care that can be delivered with fidelity and in accordance with state-of-the-science best practices into a unified, seamless digital delivery system. Digital therapeutics have been particularly transformative in the field of substance use, mental health, and other behavioral health conditions and can markedly improve access to care, quality of care, and treatment outcomes, while reducing costs, for a wide array of audiences in diverse settings.
In this presentation, Dr. Lisa A. Marsch (Dartmouth Center for Technology and Behavioral Health) will review the state of the science of digital therapeutics for behavioral health and timely opportunities to scale up access to these digital health tools via multiple paths to deployment around the world.
At the conclusion of the webinar, participants will be able to:
- Recall the key findings from at least two (2) clinical trials focused on the use of digital therapeutics in substance use disorder treatment.
- Specify at least two (2) ways that digital data capture can be used to assess health behavior and provide personalized digital therapeutics.
- Assess the confluence of at least two (2) factors that increase the demand of and opportunities for scaling up access to behavioral health digital therapeutics.
1.5 CME or CE credits available. For details on types of credit and accreditation, download our flyer.
About the presenter: Dr. Lisa A. Marsch is the Founding Director of the Dartmouth Center for Technology and Behavioral Health (CTBH), a designated “Center of Excellence” supported by the U.S. National Institutes of Health. She is also the Director of the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network and the Andrew G. Wallace Professor within the Departments of Psychiatry and Biomedical Data Science at the Geisel School of Medicine at Dartmouth College.